Back
Omnicell, Inc. 10K Form
Buy
65
OMCL
Omnicell, Inc.
Last Price:
$39.52
Seasonality Move:
-1.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | OMCL/Omnicell, Inc. Quarterly |
| 2023-11-03 | 10Q | OMCL/Omnicell, Inc. Quarterly |
| 2023-08-04 | 10Q | OMCL/Omnicell, Inc. Quarterly |
| 2023-05-05 | 10Q | OMCL/Omnicell, Inc. Quarterly |
| 2022-11-04 | 10Q | OMCL/Omnicell, Inc. Quarterly |
| 2022-08-09 | 10Q | OMCL/Omnicell, Inc. Quarterly |
Receive OMCL News And Ratings
See the #1 stock for the next 7 days that we like better than OMCL
OMCL Financial Statistics
Sales & Book Value
| Annual Sales: | $1.1B |
|---|---|
| Cash Flow: | $14M |
| Price / Cash Flow: | 19.68 |
| Annual Sales: | $27.21 |
| Price / Book: | 1.46 |
Profitability
| EPS (TTM): | 0.42640 |
|---|---|
| Net Income (TTM): | $19.9M |
| Gross Margin: | $475.5M |
| Return on Equity: | 1.6% |
| Return on Assets: | 0.93% |
Omnicell, Inc. Earnings Forecast
Key Omnicell, Inc. Financial Ratios
-
The Gross Profit Margin over the past 28 years for OMCL is 42.75%.
-
The Selling, General & Administrative Expenses for OMCL have been equal to 34.19% of Gross Profit Margin.
-
The Research & Development expenses have been 8.09% of Revenue.
-
The Interest Expense is 36.11% of Operating Income.
-
The Net Earning history of OMCL is 1.13% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 18 years.
Omnicell, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | OMCL |
| CUSIP: | 68213N |
| Website: | omnicell.com |
Debt
| Debt-to-Equity Ratio: | 0.17 |
|---|---|
| Current Ratio: | 1.41 |
| Quick Ratio: | 1.05 |
Price-to-Earnings
| Trailing P/E Ratio: | 146.22 |
|---|---|
| Forward P/E Ratio: | 21.56 |
OMCL Technical Analysis vs Fundamental Analysis
Buy
65
Omnicell, Inc. (OMCL)
is a Buy
Is Omnicell, Inc. a Buy or a Sell?
-
Omnicell, Inc. stock is rated a BuyThe current Omnicell, Inc. [OMCL] share price is $39.61. The Score for OMCL is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.